We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$88B
AUM Growth
+$3.05B
(+3.6%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
12.89%
Holding
2,253
New
146
Increased
815
Reduced
1,092
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Industrials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGIO
1251
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.1M | ﹤0.01% |
12,843
-24,921
| -66% | -$3.95M |
|
1252
The GEO Group
GEO
$4.04B
| $2.1M | ﹤0.01% |
126,140
-22,860
| -15% | -$347K |
|
1253
Halozyme
HALO
$12.2B
| $2.1M | ﹤0.01% |
118,170
-18,409
| -13% | -$319K |
|
1254
BGSF Inc
BGSF
$59.3M
| $2.09M | ﹤0.01% |
95,556
-77,990
| -45% | -$1.59M |
|
1255
Rush Enterprises Class A
RUSHA
$6.23B
| $2.09M | ﹤0.01% |
101,120
+1,971
| +2% | +$38.4K |
|
|
LCI
1256
DELISTED
Lannett Company, Inc.
LCI
| $2.09M | ﹤0.01% |
59,224
+20,153
| +52% | +$820K |
|
1257
QuidelOrtho
QDEL
$938M
| $2.09M | ﹤0.01% |
27,822
-8,142
| -23% | -$526K |
|
1258
Zurn Elkay Water Solutions
ZWS
$8.47B
| $2.09M | ﹤0.01% |
132,769
+87,421
| +193% | +$1.26M |
|
|
LHCG
1259
DELISTED
LHC Group LLC
LHCG
| $2.09M | ﹤0.01% |
15,141
-1,333
| -8% | -$166K |
|
|
ESGR
1260
DELISTED
Enstar Group
ESGR
| $2.07M | ﹤0.01% |
10,014
-2,297
| -19% | -$459K |
|
|
FPRX
1261
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.06M | ﹤0.01% |
449,403
+311,832
| +227% | +$1.24M |
|
|
RETA
1262
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.06M | ﹤0.01% |
10,077
-931
| -8% | -$170K |
|
1263
Microchip Technology
MCHP
$44.2B
| $2.04M | ﹤0.01% |
+39,000
| New | +$1.88M |
|
|
PMT
1264
PennyMac Mortgage Investment
PMT
$818M
| $2.03M | ﹤0.01% |
90,995
+71,698
| +372% | +$1.62M |
|
1265
Exponent
EXPO
$3.28B
| $2.02M | ﹤0.01% |
29,247
-1,558
| -5% | -$103K |
|
|
ENDP
1266
DELISTED
Endo International plc
ENDP
| $2.02M | ﹤0.01% |
429,958
-1,368,812
| -76% | -$6.11M |
|
1267
Universal Corp
UVV
$1.18B
| $2.01M | ﹤0.01% |
35,184
-39,597
| -53% | -$2.14M |
|
1268
DexCom
DXCM
$33.1B
| $2M | ﹤0.01% |
36,660
-18,572
| -34% | -$881K |
|
|
CFMS
1269
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2M | ﹤0.01% |
53,402
-52,425
| -50% | -$2.49M |
|
|
CXP
1270
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2M | ﹤0.01% |
95,653
+36,326
| +61% | +$745K |
|
1271
SiriusXM
SIRI
$9.7B
| $2M | ﹤0.01% |
28,064
-1,629
| -5% | -$110K |
|
1272
Alpha and Omega Semiconductor
AOSL
$1.03B
| $1.99M | ﹤0.01% |
146,120
+133,300
| +1,040% | +$1.68M |
|
|
RDUS
1273
DELISTED
Radius Recycling
RDUS
| $1.99M | ﹤0.01% |
91,670
-55,742
| -38% | -$1.19M |
|
|
ACIA
1274
DELISTED
Acacia Communications Inc
ACIA
| $1.98M | ﹤0.01% |
29,245
-4,733
| -14% | -$314K |
|
1275
Iron Mountain
IRM
$36.2B
| $1.98M | ﹤0.01% |
62,041
-14,928
| -19% | -$489K |
|
Similar funds
VGA
AQR Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, AQR Capital Management held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AQR Capital Management opened a new position in DaVita worth $31.1M.
- AQR Capital Management's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- AQR Capital Management added most to Humana in Q4 2019, an estimated $267M increase.
- AQR Capital Management's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- AQR Capital Management fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- AQR Capital Management's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- AQR Capital Management opened 146 new positions and closed 142 in Q4 2019.
- AQR Capital Management's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.